Vimarsana
Biggest News Aggregation in the World

Page 20 - Expert View News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expert View. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expert View Today - Breaking & Trending Today

earnings growth: Which part of power bucket will see highest earnings growth in next 10 years? Fitch Ratings' Girish Madan answers - Vimarsana News

earnings growth: Which part of power bucket will see highest earnings growth in next 10 years? Fitch Ratings' Girish Madan answers

Girish Madan from Fitch Ratings discusses the rise in profits for Gencos through factors like lower commodity prices and reduced solar module prices. He emphasizes the ongoing shift towards renewable generation in the power sector for enhanced profitability. He says: "Going forward, we see some push on the renewable as well as on the thermal power generation front."

stock picking: Get set for a bottoms-up market in first half of FY25: Amit Khurana - Vimarsana News

stock picking: Get set for a bottoms-up market in first half of FY25: Amit Khurana

Post March caution, markets rebounded but earnings season remains weak. Focus should be on turnaround signs or visibility in stock selection. Amit Khurana of Dolat Capital says that while battery companies have outperformed, IT midcaps remain overvalued. He is positive on capex stories but remains wary of high valuation stocks.

stocks to buy | stocks to sell: What are CA Rudramurthy BV's 2 long & 2 short calls for traders now? - Vimarsana News

stocks to buy | stocks to sell: What are CA Rudramurthy BV's 2 long & 2 short calls for traders now?

Rudramurthy advises on stock-specific trades, preferring Reliance and SBI. Suggests shorting Maruti and IndusInd Bank. Emphasizes shifting focus to largecaps for safety. Bullish on IT sector for future growth and stability.

biopharma companies: Expect Syngene revenue to grow from high single digits to low double digits next year: Jonathan Hunt - Vimarsana News

biopharma companies: Expect Syngene revenue to grow from high single digits to low double digits next year: Jonathan Hunt

Jonathan Hunt detailed the investment strategy of Syngene International, facing revenue growth challenges due to US biotech funding delays. Expecting high single to low double digits growth for FY25, with ongoing developments in various company facilities. Hunt says: "We deployed $55 million last year. Next year, we will be a little bit ahead of that."

Bajaj Finance Q4 result: Bajaj Finance should continue to maintain 20-25% growth despite RBI restrictions: Binod Modi - Vimarsana News

Bajaj Finance Q4 result: Bajaj Finance should continue to maintain 20-25% growth despite RBI restrictions: Binod Modi

Binod Modi discusses Bajaj Finance's performance, including credit cost, growth potential, and asset quality concerns. Despite challenges like RBI restrictions and delinquencies, the company aims for growth through digital initiatives, facing competition and valuation risks.